Schedule 13G ownership disclosure

Coherus Oncology Inc

Security class unavailable · CUSIP: 19249H103

Event date: 2017-12-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,259,398
Percent of class
12.5300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-18-000094
Form type
SC 13G/A
Filer
Coherus Oncology, Inc.
CIK
CIK 1512762
Filed
Feb 08, 2018
Reporting period
Dec 29, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub